Key facts
- Starling Medical’s last known valuation is $15.8M (Mar 2026).
- It has raised $10.5M across 2 recorded rounds; the latest was Seed Round ($825K) in Feb 2026.
- Notable investors include Y Combinator, US National Science Foundation, MassChallenge, MedTech Innovator, Gaingels — 26 tracked in total.
- Starling Medical has filed 2 Form Ds with the SEC, most recently Dec 2024 ($8.9M sold to 40 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 26 names
- ·Watchlist + deal alerts for Starling Medical
Funding rounds
2 roundsAbout Starling Medical
Developer of an at-home well-being monitoring device designed to enable continuous tracking of urinary health and support early detection of potential conditions. The company offers a connected device with real-time health insights, nurse-supported monitoring, provider integration, and a user-facing mobile interface, enabling patients and healthcare providers to manage preventative care and respond to health changes promptly.
- Sector
- Healthcare
- HQ
- Houston, TX, United States
- Founded
- 2019
- Employees
- 10
- Website
- starlingmedical.com/
- Ownership
- Privately Held (backing)
Starling Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Starling Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Starling Medical in its N-PORT filings yet. We sweep new filings monthly.